Sorry, you need to enable JavaScript to visit this website.

Pfizer is proud of its long history of successfully partnering with external organizations that share in our purpose to deliver breakthroughs that change patients’ lives.

We engage in partnerships with innovators to push forward great science and continually seek new partners that are actively researching bold scientific ideas, capabilities and technologies that have the potential to bring innovative treatments to patients in need. Pfizer has several key areas of interest where we are looking to partner with others.

pfizer partner

Partnering Models

What are you looking for in a partnership? Pfizer engages in flexible partnership models that includes research collaborations, venture capital investments, academic alliances for drug development, early stage seed funding, establishing incubators, licensing, and spinning out of companies.

Start a conversation with us. Let's learn about each other and discover synergies, goals, needs and capabilities. There are patients who are waiting, and together, we might deliver on the promise of better health and longer lives.

Academic & Public Partnerships

We engage with academia and other public bodies in a range of partnerships, some models include:

Contacts:

Biotechnology Partnerships

Our biotech partnerships allow us to help you bring your drug or platform to market, with a focus on:

  • Licensing options
  • Acquisition

Contacts:

Venture Investments

Our equity investments are active partnerships that seek to identify, support and grow good science from an early stage.

Contacts:

Using Viruses to Fight Cancer: A New Approach to Treating Solid Tumors

Today, more people are surviving cancer than ever before, thanks to advances in diagnosis and treatment. Now, a new treatment technology being developed – oncolytic virus therapy – may lend hope for patients battling locally advanced or metastatic solid tumors.

Read More

Categories

Keywords

  • All Keywords
May 2021
April 2021
March 2021
February 2021
January 2021

Pfizer Ventures invests in private companies at all stages of development, with a strong focus on early stage opportunities.  

Learn About Pfizer Venture Investments

Pfizer CentreOne® is a global contract development and manufacturing organization (CDMO) embedded within Pfizer and a leading supplier of specialty APIs

Learn About Pfizer CentreOne®

Have an idea? Send us your opportunity for consideration.

Submit Your Opportunity

To streamline transactions with our suppliers and wholesale distributors, we’ve designed a Business-to-Business portal.